Milligan Sandra (CIK 0001859810)

Latest company ownership

GOSS - Gossamer Bio, Inc.
Role: Director
Shares held
58,050
Last filed at
Aug 20, 2025
Confidence Score
58.4
2025Q4
Confidence Score History
2023Q4 2025Q4
Shares held
20,000
Last filed at
Jan 29, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q4 2025Q4
OGN - Organon & Co.
Role: Head of Research & Development
Shares held
4,989
Last filed at
May 8, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 19, 2025 Aug 20, 2025 Gossamer Bio, Inc. Director Buy 95.0 +26,050 81.41% ✗ $50K
Dec 31, 2024 Jan 29, 2025 Aspira Women's Health Inc. CEO Sell 47.5 -6,356 -31.78% ✗ $4.4K
Nov 15, 2023 Nov 17, 2023 Gossamer Bio, Inc. Director Buy 91.3 +32,000 100.00% ✗ $25.2K
May 4, 2023 May 8, 2023 Organon & Co. Head of Research & Development Sell 22.5 -2,168 -7.05% ✗ $52.6K
May 1, 2023 May 3, 2023 Organon & Co. Head of Research & Development Sell 26.3 -826 -3.10% ✗ $20.3K
Mar 31, 2023 Apr 4, 2023 Organon & Co. Head of Research & Development Sell 26.3 -2,115 -7.88% ✗ $48.8K
Feb 28, 2023 Mar 2, 2023 Organon & Co. Head of Research & Development Sell 22.5 -2,346 -10.11% ✗ $58.9K
May 3, 2022 May 5, 2022 Organon & Co. Head of Research & Development Sell 22.5 -2,331 -7.87% ✗ $75.4K
May 1, 2022 May 3, 2022 Organon & Co. Head of Research & Development Sell 26.3 -540 -4.79% ✗ $17.5K
Feb 28, 2022 Mar 2, 2022 Organon & Co. Head of Research & Development Sell 22.5 -2,941 -23.87% ✗ $110.5K